Delivery Order SPE2DB20D3303-SPE2DB24FY9E7

Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $14K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,007.71 contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any particular business type....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a potential value of $27,175.99 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract has a completion date of February 22, 2024 and a potential value of $12,030.84. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract was issued under...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 45 MG TABLET in quantities of 28. The completion date for this $6,863.94 contract is January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,084.60 contract is for the delivery of RINVOQ ER 15 MG TABLET, a specialty pharmaceutical product, with a performance period through April 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract has a potential value of $4,685.46 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 30 MG TABLET UU 30S. The contract has a potential value of $16,973.25 and a performance period through January 29, 2024. Amerisourcebergen Drug Corporation is the prime contractor, with no set-aside designation indicated. This delivery order is issued under a larger indefinite...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $25,278.07 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of the prescription drug RINVOQ ER 15 MG TABLET. This order falls under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,102.54 firm fixed price delivery order to supply RINVOQ ER 30 MG TABLET UU 30S. This order, which has a completion date of January 22, 2024, is part of Amerisourcebergen's existing indefinite delivery contract with DLA Troop Support Medical to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside designation...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FY9E7
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $13,866.16 contract is for the supply of the prescription drug RINVOQ ER 15 MG TABLET. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this award. The contract has a completion date of February 7, 2024 and was awarded on February 6, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 5/7/24, 12:06 PM